EPO


The European Patent Office (EPO) is an organ of the European Patent Organisation, an intergovernmental organisation that was set up on 7 October 1977 on the basis of the European Patent Convention (EPC) signed in Munich in 1973. The EPO is responsible for the uniform procedure to grant European patents. Once the EPO has granted a European patent, the patent holder can validate it in every single contracting state. In the future, the EPO will also be in charge of deciding on requests for unitary effect of European patents under the Unitary Patent system.


256 articles available

Eight years (!) after complaints of dozens of EPO staff members against the way they were treated after having participated in strikes, a final decision in their cases is finally there: former EPO…

“The Annual Review 2020 shows that demand for European patents remained nearly on a par with last year. The Office received a total of 180 250 European patent applications, 0.7% fewer than in 2019…

A board of appeal of the EPO held that for the problem-solution approach to inventive step the requirement of the same “purpose or effect" in the criteria for selecting the closest prior art for a…

The interplay between EPO and national proceedings may take various forms. The Technical Board of Appeal revoking a European Patent during European-wide litigation is one of the more dramatic…

A reminder of the good old days, when many things were still normal... I. Nemo Iudex Once upon a time, the "nemo iudex" principle was a fundamental cornerstone of EPO Board Appeal proceedings, even…

The ‘new normal’ at the EPO and more particularly plans to allow oral proceedings by videoconference even if parties don’t want it, have been leading to extensive debate over the last weeks. No less…

The European Patent Office has invited its users and stakeholders to take position on the first draft of its „Towards a new normal“ orientation document. My experience with such public consultations…

Although the case relates to treatments for insomnia, we suspect that the latest episode in the ongoing saga between Neurim and Mylan might result in a few sleepless nights for patent litigators…

In the first part of this interview (see here), I already mentioned some of the preconceived ideas about French Courts, which makes France almost systematically considered as one of the last…